𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia

✍ Scribed by Lisa Maher; Bin Jalaludin; Kerry G. Chant; Rohan Jayasuriya; Tim Sladden; John M. Kaldor; Penny L. Sargent

Book ID
108597691
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
131 KB
Volume
101
Category
Article
ISSN
0965-2140

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prevalence of hepatitis B virus and risk
Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users
✍ Renata C. Ferreira; Fabiana P. Rodrigues; Sheila A. Teles; Carmen L.R. Lopes; An πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

## Abstract Non‐injecting drug users are at high‐risk for acquiring hepatitis B virus (HBV), although the factors contributing to this increased risk are not known. In the present study, the overall and occult HBV infection prevalence rates were determined in a large population of non‐injecting dru

High incidence of hepatitis C virus rein
High incidence of hepatitis C virus reinfection in a cohort of injecting drug users
✍ Campbell Kynoch Aitken; Jennifer Lewis; Samantha Lilly Tracy; Timothy Spelman; D πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 160 KB πŸ‘ 2 views

An estimated 170 million people worldwide carry the hepatitis C virus (HCV), and in more developed countries the prevalence and incidence of HCV is particularly high among injecting drug users (IDUs). Spontaneous clearance of HCV infection and reinfection is well recognized but the level of protecti